Bristol Myers Squibb to Participate in the TD Cowen 44th Annual Health Care Conference
26 Febrero 2024 - 3:16PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in the TD Cowen 44th Annual Health Care
Conference in Boston, Massachusetts, on Monday, March 4, 2024.
Roland Chen, M.D., senior vice president, Immunology,
Cardiovascular & Neuroscience development, will answer
questions about the company during a fireside chat at 9:50 a.m.
ET.
Investors and the general public are invited to listen to a live
webcast of the session here. An archived edition of the session
will be available following its conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop, and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240226516046/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Bristol Myers Squibb (NYSE:BMY)
Gráfica de Acción Histórica
De May 2023 a May 2024
